Teva Pharmaceutical Industries Ltd. announced the final analysis of the PEARL Phase 4 study at the European Academy of Neurology Congress 2025, confirming that AJOVY (fremanezumab) is effective in ...

A copy of the Company’s poster presentation will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference.

SEOUL, June 3, 2025 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee) announced that it presented interim results from a global Phase 2 clinical trial of its ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) has unveiled new data at the 2025 Psych Congress Elevate, highlighting significant advances in schizophrenia treatment.

Reflecting their market trajectories, Lilly has replaced Novo Nordisk at the top of IDEA Pharma's rankings of the most innovative biopharma companies.

Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis largely balanced and representative of targeted trial ...

IDEA Pharma ranks firms on invention of new drugs and innovation, the ability to get those new drugs to market. Eli Lilly, AstraZeneca top 2025 lists.

Press Release Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that its Trials in Progress abstract has ...